E.E. Geduld’s Puma Biotechnology PBYI Stock Holding History

E.E. Geduld’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-5,030	Closed	-$332K	–	269
2014 Q2	$332K	Sell	5,030 -2,600	-34%	-$185K	0.21%	123
2014 Q1	$795K	Buy	7,630 +2,600	+52%	+$306K	0.43%	48
2013 Q4	$521K	Sell	5,030 -15,000	-75%	-$880K	0.25%	85
2013 Q3	$1.07M	Hold	20,030	–	–	0.66%	28
2013 Q2	$889K	Buy	+20,030	New	+$706K	0.63%	29

Other funds holding PBYI

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

E.E. Geduld's PBYI Position: Q3 2014 in Review

E.E. Geduld sold out of Puma Biotechnology (PBYI) in Q3 2014, closing a stake of 5,030 shares — an estimated $332K sold.

E.E. Geduld first reported a position in PBYI in Q2 2013 and held it in 5 quarters. The position peaked at $1.07M in Q3 2013. 184 funds tracked by Wall St. Rank hold PBYI as of Q3 2014.

E.E. Geduld reported no remaining Puma Biotechnology position as of Q3 2014 after selling out during the quarter.
E.E. Geduld sold 5,030 Puma Biotechnology shares in Q3 2014, an estimated $332K.
E.E. Geduld first reported a position in Puma Biotechnology in Q2 2013 and held it in 5 quarters.
E.E. Geduld's Puma Biotechnology position peaked at $1.07M in Q3 2013.
184 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2014.

Based on E.E. Geduld's 13F filing for Q3 2014, filed 30 Oct 2014.